Ovid Therapeutics (OVID) Non-Current Assets (2016 - 2026)
Ovid Therapeutics (OVID) reported Non-Current Assets of $108.36 million for Q2 2026, up 206.6% from $35.34 million a year earlier and up 65.5% from the prior quarter.
Powered by 
Analysis
Ovid Therapeutics (OVID) Non-Current Assets (2016 - 2026) Analysis & Trends
At the end of FY2025, Ovid Therapeutics posted Non-Current Assets of $76.57 million, up 111.4% from FY2024.
- Non-Current Assets has increased for six consecutive years, with a five-year compound annual growth rate of 134.4% (FY2020 to FY2025).
- By year, Non-Current Assets came in at $36.23 million in FY2024 (+5.2%), $34.43 million in FY2023 (+44.1%), $23.89 million in FY2022 (+487.5%) and $4.07 million in FY2021 (+275.6%).
- The Q2 2026 figure ranks as the highest quarterly Non-Current Assets in data going back to Q4 2016.
- Year over year, Non-Current Assets has now increased in each of the last three quarters, with growth averaging 50.0% over the last eight quarters.
- The high point for year-over-year Non-Current Assets in five years was Q2 2022 (growth of 899.1%); the low point was Q1 2025 (a decline of 7.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $65.48 million (Q1 2026), $76.57 million (Q4 2025) and $35.02 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Ovid Therapeutics | 454.50 Mn | 86.52 Mn | - | 108.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 108.36 Mn |
| Mar 31, 2026 | 65.48 Mn |
| Dec 31, 2025 | 76.57 Mn |
| Sep 30, 2025 | 35.02 Mn |
| Jun 30, 2025 | 35.34 Mn |
| Mar 31, 2025 | 35.73 Mn |
| Dec 31, 2024 | 36.23 Mn |
| Sep 30, 2024 | 36.83 Mn |
| Jun 30, 2024 | 37.20 Mn |
| Mar 31, 2024 | 38.44 Mn |
| Dec 31, 2023 | 34.43 Mn |
| Sep 30, 2023 | 33.32 Mn |
| Jun 30, 2023 | 34.06 Mn |
| Mar 31, 2023 | 23.85 Mn |
| Dec 31, 2022 | 23.89 Mn |
| Sep 30, 2022 | 24.53 Mn |
| Jun 30, 2022 | 21.25 Mn |
| Mar 31, 2022 | 21.01 Mn |
| Dec 31, 2021 | 4.07 Mn |
| Sep 30, 2021 | 2.03 Mn |
API Access
Ovid Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=OVID&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "OVID", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=OVID&period=max&api_key=YOUR_API_KEY");
const data = await res.json();